Cagrilintide for Appetite Control
Research, mechanism, dosing, and effectiveness of Cagrilintide for appetite control.
Quick Answer
Amylin analogs provide satiety signaling from the pancreas.
Evidence Level
Human Trials
Typical Dose
Weekly injection
Results Timeline
Appetite effects within weeks
FDA Status
Research Only
How Cagrilintide Works for Appetite Control
Activates amylin receptors to reduce food intake.
About Appetite Control
Suppression of hunger signals and improved satiety for weight management.
Research Evidence
REDEFINE 1 Phase 3 trial showed 11.8% weight loss with cagrilintide monotherapy vs 2.3% placebo over 68 weeks. Combined with semaglutide (CagriSema), average weight loss reached 20.4% vs 3.0% placebo. 60% of CagriSema participants achieved ≥20% weight loss, and 23% lost ≥30%. This represents some of the most significant weight loss results seen with any anti-obesity medication.
Dosing for Appetite Control
Recommended Dose
Weekly injection
Frequency
Once weekly
Administration
Subcutaneous injection once weekly
Duration
Long-term / chronic use expected
Note: Most effective when combined with semaglutide (CagriSema). Works through amylin pathway which is complementary to GLP-1 mechanism. Dose escalation typically used to minimize GI side effects. Not yet commercially available - still in clinical trials.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Nausea (common, usually transient)
- •Vomiting
- •Diarrhea
- •Constipation
- •Abdominal pain
- •Injection site reactions
Frequently Asked Questions
Does Cagrilintide help with appetite control?
Amylin analogs provide satiety signaling from the pancreas.
How does Cagrilintide work for appetite control?
Activates amylin receptors to reduce food intake....
What dose of Cagrilintide should I use for appetite control?
Weekly injection
How long until I see results?
Appetite effects within weeks
Other Peptides for Appetite Control
These peptides are also researched for appetite control.
Semaglutide
FDAA GLP-1 receptor agonist with multiple FDA approvals including weight loss, T2D, CV risk reduction, and kidney protection. Wegovy pill approved Dec 2025 as first oral GLP-1 for weight loss.
Liraglutide
FDAAn FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management. The predecessor to semaglutide with daily dosing.
Retatrutide
Clinical TrialsA triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 trials show up to 28.7% weight loss (71 lbs average), the highest of any obesity drug. Expected FDA approval late 2026 to early 2027.
Survodutide
Clinical TrialsA dual GLP-1/glucagon receptor agonist in development for obesity and MASH. Has FDA Breakthrough Therapy Designation for MASH with fibrosis.
Educational Information Only
This information about Cagrilintide for appetite control is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.